Our PR and IR tools are designed to meet all necessary regulatory requirements, giving you the confidence to communicate effectively and compliantly. Streamline your communications needs today with our one-stop shop offering.
Private CompaniesWhether a startup or established brand, we deliver the support, targeted distribution, media outreach, and flexible pricing & payment options needed to amplify your story with confidence.
AgenciesWe simplify the process of delivering success for both you and your clients. We understand the importance of getting it right, equipping you with seamless billing, flexible plans and payment structures, and clear reporting and analytics to ensure every campaign runs smoothly and achieves measurable results.
We understand the need to manage high volume of press release distribution efficiently. That's why we offer a dedicated API designed specifically for our legal customers, delivering a streamlined, simple process that ensures value and ease at every step.
Resellers, Publishers & Market ResearchWe understand the importance of cost efficiency for high-volume partners, which is why we offer bulk discounts tailored to meet your needs while maximizing value.
MTF body feminization surgery is becoming an increasingly important part of gender-affirming care as more transgender women seek procedures that create a feminine body contour. Dr. Javad Sajan, a Seattle based renJowned plastic surgeon specializing in gender-affirming surgery, provides customized MTF body feminization surgery and accepts insurance for eligible procedures at his clinic, Allure Esthetic. His approach combines advanced body...
Read more
Advertorial. This content is promotional in nature and is intended for consumer education regarding a commercially available product. A commission may be earned if you purchase through links in this article. Product claims are attributed to the brand and aren't independently endorsed. Compounded semaglutide and tirzepatide aren't FDA-approved - FDA doesn't review compounded drugs for safety, effectiveness, or quality before they're marketed....
Read more
Quick disclosure before you read further: this is a paid advertorial, and this content is promotional in nature and intended for consumer education regarding a commercially available product. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. ClearVue+ is a dietary supplement - not a drug, not FDA-approved, and per the brand's own disclaimer, not...
Read more
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, today reported financial results for the three and six months ended June 30, 2026, and provided a corporate update highlighting significant regulatory, clinical and strategic achievements across its development portfolio. During the second...
Read more
Quick disclosure before you read further: this is a paid advertorial. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. HumeCare connects patients with an independent licensed medical group. Compounded GLP-1 medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing quality. This article does...
Read more
Quick heads-up before we dive in: this is a paid advertorial, and a commission may be earned if you purchase through the links here. Product claims are attributed to the brand and aren't independently endorsed. Pallas Health's NAD+ program is a compounded prescription medication - not a dietary supplement - that isn't FDA-approved and hasn't been evaluated by the FDA for safety, effectiveness, or quality. Official site: pallashealth.co. Reviewed...
Read more
Beckman Dry Eye Institute, a newly opened medical practice dedicated exclusively to the diagnosis and treatment of dry eye disease, today announced the addition of Tixel i, a precision device for evaporative dry eye caused by Meibomian Gland Dysfunction, and Tixel 2, an advanced non-laser skin rejuvenation device, to its growing portfolio of treatment technologies. The addition of these devices enables the institute to provide comprehensive,...
Read more
Archer First Response Systems (ArcherFRS) underscored its central role in enabling the nation's first EMS-driven pre-hospital whole blood drone delivery program, developed in partnership with Hillsborough County Fire Rescue (HCFR), Tampa General Hospital (TGH), the University of South Florida Health Morsani College of Medicine, and the Florida Center for Emergency Medical Services. The program will station ArcherFRS systems at two HCFR stations...
Read more
HomeAid America, a national nonprofit organization dedicated to ending homelessness in the United States, today announced that Toll Brothers, the nation's leading builder of luxury homes, honored HomeAid for the second consecutive year at its 32nd Annual Gala held this past May at the historic Bellevue Hotel in Philadelphia. Combined with other fundraising efforts held by Toll Brothers divisions across the country, the Company donated a total of...
Read moreWorking Together, Working for Better At DaVita, people are the foundation of our community and the driving force behind our pursuit of a healthier tomorrow for all. Rooted in our identity as a community first and a company second, we foster an environment where every teammate can thrive, feel supported and contribute meaningfully. Our culture is built on shared purpose, meaningful connection, authentic belonging and professional growth that...
Read more
Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced it has entered into warrant inducement letter agreements with certain holders of its existing common warrants (the "Existing Warrants"), pursuant to which such holders have agreed to exercise in full for cash their Existing Warrants to purchase up to an aggregate...
Read morevCare, a women's intimate wellness company, said today that demand for its at-home red light device has surged following publication of new peer-reviewed research examining the 660-nanometer wavelength the device uses for menopause-related symptoms. The vCare Red Light Device combines 660nm red light, therapeutic warmth, and targeted vibration for at-home use. (Photo: vCare) The study, published in June in PLOS ONE by researchers at National...
Read more
Valion Bio, Inc. (Nasdaq:VBIO), a late-stage innate immunotherapeutics company, today announced that the Armed Forces Radiobiology Research Institute (AFRRI), under its contract with the National Institute of Allergy and Infectious Diseases (NIAID), is conducting a U.S. Department of War (DoW) government-funded program evaluating Entolimod for radiation-induced gastrointestinal (GI) injury. The program is expected to advance through a safety...
Read more
Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the positioning of its StrainScan Pro platform for the global foodservice sector, targeting restaurants, commercial kitchens, and high-volume food operations with proprietary AI vision software optimized for enterprise deployment on iPad Air devices. The global foodservice and restaurant market represents one of the largest consumer-facing industries worldwide, with estimates...
Read more
Quick heads-up before we dive in: this is a paid advertorial, and a commission may be earned if you buy through the links here. This content is promotional in nature and is intended for consumer education regarding a commercially available product. Claims below come from Pallas Health and aren't independently endorsed. Pallas is a telehealth platform, not a pharmacy or a medical practice - prescription medication is only available after a...
Read moreAcross the United States, healthcare organizations continue to face workforce shortages, rising demand for care, and increasing pressure to recruit and retain qualified clinicians. While staffing agencies have traditionally focused on filling open positions quickly, industry leaders say the future of healthcare staffing will depend on something far more sustainable: putting people first. Eclat Healthcare Staffing LLC believes the next generation...
Read more
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2026 and provided an update on the corporate strategy the company introduced in March 2026. "We are moving with speed and discipline to transform this company," said Rami Levin, President...
Read more
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, today announced positive results from a research study conducted by Defence Research and Development Canada - Suffield Research Centre ("DRDC") evaluating bucillamine in an established animal model of nerve-agent exposure. The study...
Read more
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today provided an update on the Company's...
Read moreBioAdaptives, Inc. (OTCID:BDPT) announced the official commercial launch and pre-order availability of XcellaraHeart™, a breakthrough, pharmaceutical-grade daily cardiovascular supplement. XcellaraHeart™ is the flagship product of the company's new Xcellara™ cellular wellness platform-a series of seven targeted formulas designed to support organ-specific cellular repair and tissue maintenance. XcellaraHeart™ is the first and only cardiovascular...
Read more
